Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor Pro, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers cervical products comprising Spider cervical plating, Streamline OCT system, and CervAlign systems; thoracolumbar products, such as of Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation, and HPS 2.0 hybrid performance systems; Silex sacroiliac joint fusion systems; interbody products comprising Calix for cervical and thoracolumbar applications, Irix-C Cervical and Irix-A lumbar integrated dusion systems, and Fortilink implants; Contact ALP (Anterior Lumbar Plate) System; and interlaminar stabilization products, such as Coflex device for lumbar spinal stenosis; and CoFix implants for back and disc pain. The company is headquartered in Belgrade, Montana.
The current price of XTNT is $0.6 USD — it has increased by +3.23% in the past 24 hours. Watch Xtant Medical stock price performance more closely on the chart.
What is Xtant Medical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Xtant Medical stocks are traded under the ticker XTNT.
Is Xtant Medical stock price growing?▼
XTNT stock has risen by +10.31% compared to the previous week, the month change is a +34.08% rise, over the last year Xtant Medical has showed a +18.74% increase.
What is Xtant Medical market cap?▼
Today Xtant Medical has the market capitalization of 84.55M
When is the next Xtant Medical earnings date?▼
Xtant Medical is going to release the next earnings report on July 30, 2026.
What is Xtant Medical revenue for the last year?▼
Xtant Medical revenue for the last year amounts to 234.53M USD.
What is Xtant Medical net income for the last year?▼
XTNT net income for the last year is -32.9M USD.
How many employees does Xtant Medical have?▼
As of May 06, 2026, the company has 217 employees.
In which sector is Xtant Medical located?▼
Xtant Medical operates in the Health & Wellness sector.
When did Xtant Medical complete a stock split?▼
The last stock split for Xtant Medical was on February 14, 2018 with a ratio of 1:12.
Where is Xtant Medical headquartered?▼
Xtant Medical is headquartered in Belgrade, United States.